Skip to main content

Table 2 Adverse events related to MARS® therapy in all patients

From: Adverse events, short- and long-term outcomes of extra corporeal liver therapy in the intensive care unit: 16 years experience with MARS® in a single center

 

Overall

Acute-on-chronic liver failure

Acute liver failure

Post-surgery liver failure

Refractory pruritus

Drug intoxication

Admissions

Sessions

Admissions

Sessions

Admissions

Sessions

Admissions

Sessions

Admissions

Sessions

Admissions

Sessions

n = 180

n = 513

n = 56

n = 165

n = 32

n = 99

n = 28

n = 71

n = 52

n = 149

n = 12

n = 29

Cannula-related complications

Culture proven infection of cannula

3(1.7)

3(0.6)

3(5.4)

3(1.8)

0(0)

0(0)

0(0)

0(0)

0(0)

0(0)

0(0)

0(0)

Cannula site bleeding

10(5.6)

10(1.9)

6(10.7)

6(3.6)

0(0)

0(0)

2(7.1)

2(2.8)

2(3.8)

2(1.3)

0(0)

0(0)

Cannula dysfunction

5(2.8)

5(1.0)

1(1.8)

1(0.6)

0(0)

0(0)

0(0)

0(0)

4(7.7)

4(2.7)

0(0)

0(0)

Cardiac arrhythmia related to cannula insertion

2(1.1)

2(0.4)

1(1.8)

1(0.6)

0(0)

0(0)

0(0)

0(0)

1(1.9)

1(0.7)

0(0)

0(0)

Circuit-related complications

Coagulation of the circuit or membrane

36(20.0)

42(8.2)

13(23.2)

15(9.1)

8(25.0)

10(10.1)

4(14.3)

4(5.6)

8(15.4)

10(6.7)

3(25.0)

3(10.3)

Hypothermia

34(18.9)

34(6.6)

15(26.8)

15(9.1)

3(9.4)

3(3.0)

9(32.1)

9(12.7)

5(9.6)

5(3.3)

2(16.7)

2(6.9)

Arterial hypotension

21(11.7)

26(5.1)

7(12.5)

9(5.5)

3(9.4)

6(6.1)

5(17.9)

5(7.0)

4(7.7)

4(2.7)

2(16.7)

2(6.9)

Thrombocytopenia associated to MARS®

Preemptive platelets transfusion

30(16.7)

36(7.0)

15(26.8)

19(11.5)

5(15.2)

6(6.1)

9(32.1)

10(14.1)

1(1.9)

1(0.7)

0(0)

0(0)

MARS®-associated thrombocytopenia

55(30.6)

65(12.7)

20(35.7)

25(15.2)

13(40.6)

14(14.1)

10(35.7)

12(16.9)

8(15.4)

9(6.0)

4(33.3)

5(17.2)

Neurologic events

Epileptic seizure

3(1.7)

3(0.6)

1(1.8)

1(0.6)

1(3.1)

1(1.0)

1(3.6)

1(1.4)

0(0)

0(0)

0(0)

0(0)

CNS hemorrhage

1(0.6)

1(0.2)

0(0)

0(0)

1(1.0)

1(1.0)

0(0)

0(0)

0(0)

0(0)

0(0)

0(0)

  1. Adverse events are presented by admission and by session for each group, n(%)
  2. CNS, central nervous system